The National Institutes of Health is establishing a Multi-Omics for Health and Disease Consortium, with approximately $11 million awarded in the consortium’s first year of funding. The program aims to advance the generation and analysis of “multi-omics” data for human health research and seeks to award approximately $50.3 million over…

Seeking to illuminate bottle genomics in the use of genomic data Illumina announces the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics package provides a comprehensive, private, cloud-based data platform that allows customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable,…

Canopy Biosciences, a provider of gene editing and gene expression products and services, has acquired Zellkraftwerk for an undisclosed price, in a deal designed to expand the buyer into a “multi-omics” company offering genomics expertise with cell and tissue analysis solutions. By expanding its gene editing and genomics analysis portfolio…

Sponsor: Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile”. Register for Webinar

Researchers have constructed the first-ever predictive model of inflammatory bowel disease (IBD), revealing the complexity of its immune network through a multi-omics approach—a complexity that they hope will yield potential targets for new treatments. The model consists of individual networks constructed using molecular data generated from intestinal tissue samples isolated…

Moderna and Immatics are collaborating to “pioneer novel and transformative therapies for cancer patients with high unmet medical needs,” in a deal worth potentially $1.7B+. They will combine Immatics’ T cell receptor (TCR) platform with Moderna’s mRNA technology, and span modalities including bispecifics, cell therapy, and cancer vaccines.  Cambridge-based Moderna…

Researchers at the Salk Institute and at the University of California, San Diego (UCSD), have discovered in a mouse model how altered bile acids resulting from high-fat diets (HFDs) increase the risk of colorectal cancer. The research, published in Cell Reports, showed that HFDs can change the microbiome and in…

Researchers at Harvard Medical School and National Cheng Kung University in Taiwan have developed a new artificial intelligence (AI) tool that examines tumor sample images to provide doctors with prognoses and guidance on the most appropriate treatments for colorectal cancer. According to the team, the tool can discern how aggressive…

Originally Aired: April 20, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET VIEW NOW Biomedical informatics has come so far as an industry with advanced quantitative and computational methods that are solving challenging problems across the expanding spectrum of biology and medicine. With that expansion has come an ever-growing data deluge that…

Computational precision medicine company Genialis, which leverages artificial intelligence (AI) and machine learning (ML) to model underlying disease biology, announced it raised $13 million in a Series A financing. The company will use the proceeds to fund continued development of its ResponderID computational disease modeling platform to expand its roster…

A study led by Icahn School of Medicine at Mount Sinai has identified and mapped methylation across a number of different genetic regions associated with Alzheimer’s disease to try and better understand how epigenetic factors may influence disease onset and progression. Alzheimer’s disease is the most common form of dementia…

The genomic data platform Lifebit has teamed up with PlumCare RWE in Delaware to help a Greek genomics initiative detect rare genetic diseases in newborn babies.  The initiative, dubbed BeginNGS, is supported by the Rady Children’s Institute for Genomic Medicine in San Diego in addition to Greece’s National Organization of…

Newly identified markers of atherosclerotic coronary artery disease (ASCAD) were pinpointed in a study using digital twins. The work was carried out by multi-omics specialist G3 Therapeutics and AI company Aitia, which has Gemini Digital Twin technology. These new findings suggest triglyceride-rich LDL particles could be a novel diagnostic marker…

Researchers at the Fred Hutchinson Cancer Center, conducting a broad, comprehensive analysis of more than 100,000 cases of colorectal cancer (CRC) have identified 100-plus new genetic risk factors strongly linked with the disease. The findings, published in Nature Genetics, demonstrating the power of using big data—combining a large-scale study with…

AI-driven pharmatech company Exscientia announced today that it has commenced an oncology drug discovery and development collaboration with the University of Texas MD Anderson Cancer Center to identify novel anti-cancer, cell-intrinsic small-molecule compounds based on jointly identified therapeutic targets. The researchers at MD Anderson’s Therapeutics Discovery division will use Exscientia’s…